Prophylactic paclitaxel-eluting stent placement does not improve covered femoropopliteal stent patency
Objective: Covered stents are an important tool in managing femoropopliteal peripheral arterial disease. However, their performance is impaired by edge neointimal hyperplasia and restenosis. We examined the effectiveness of prophylactic deployment of paclitaxel-eluting stents to prevent edge resteno...
Saved in:
Main Authors: | Rory Marples, MBBS, Matthew Binks, MBBS, Roberto Spina, MBBS, MSc, MPH, FRACP, Melissa Wright, MD, Ravi Huilgol, MBBS, FRACS |
---|---|
Format: | article |
Language: | EN |
Published: |
Elsevier
2022
|
Subjects: | |
Online Access: | https://doaj.org/article/151040d0d3a44a95b7e70b56e61a2849 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine
by: Ikushima I, et al.
Published: (2011) -
Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent
by: Litsky J, et al.
Published: (2014) -
Head-to-head comparison of sirolimus-eluting stents versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of 76 studies.
by: Xinlin Zhang, et al.
Published: (2014) -
Everolimus-eluting coronary stents
by: Alejandro Saez, et al.
Published: (2010) -
Saphenous Vein Graft Aneurysm after Drug-Eluting Stent Implantation: Treatment by Covered Stent
by: Kyriacos Papadopoulos, et al.
Published: (2021)